PREFACE TO THE SECOND EDITION –
2016: CASE STUDIES
“AUTOBLOOD – THE MAGIC SHOT”
Stuart Hale Shakman – July 25 2016
©2016 S H Shakman
This volume was originally published in an 8 x 10 format
as The Autohemotherapy
Reference Manual. This
second edition is being reissued in a 6 x 9 inch format as “Autoblood: The Magic Shot”
(alternate title per publisher requirement). Contents of the
original publication are being fully retained as they are not
otherwise available through Medline, etc.
We are reminded of:
-
autohemotherapy’s history in a range of diseases (as documented
herein);
- its tradition as a “treatment of last resort” in
otherwise hopeless cases;
- its potential for service against AIDS, ebola, dengue
fever, zika, etc.;
- its logical use for sepsis, which by definition
involves antigen in blood;
- its role in immunotherapy vis a vis blocking metastasis
of carcinoma;
- and its no-brainer potential as a tool to be integrated
into basic first aid.
Beyond re-emphasis on the continuing value of this
original publication, this “Preface to the Second Edition”
highlights notable recent developments:
(1) the growth in popularity of
autohemotherapy in Latin America;
(2) alternate modern “guises” of
autohemotherapy;
(3) growing use of stem cells
from blood rather than from bone marrow; and
(4) the continuing association of
autologous methods with cancer; plus:
--- Remembering
"Autohemotherapist" Sam Tasker (1907-1999) ---
(1)
Popularity of autohemotherapy in Latin America.
Searching Google for alternate
terms, the dominance of “autohemoterapia” vs “autohemotherapy” –
seemingly reflects the particular interest in autoblood therapy
in Latin America, e.g., Brazil, as well as in Mexico.
Particularly well known in Brazil is the “crusading” work
of Dr. Luiz Moura, who has been practicing autohemotherapy since
the 1940s, taking the mantle from his father who was also a
doctor. Dr. Moura and associates have been engaged in
controversy with governmental and medical authorities, who have
sought to outlaw the practice.
Advocates have organized with the “Campanha Nacional Em
Defesa Da Auto-Hemoterapia” which seems to have been effective
to date in keeping the practice available.. Dr. Moura in
particular has been very active in promoting awareness of
autohemotherapy through a series of youtube.com videos. See youtube.com.
(2)
Alternate “guises” of autohemotherapy.
Over the years
many, if not most, therapies that have involved extravascular
reinjection of autologous blood or serum seemingly have not been generally
categorized as “autohemotherapy” as such. Nonetheless the same
or associated underlying physiologic processes seemingly are
involved.
Some prominent modern methods that have received popular
attention:
(a) autologous (whole) blood injection (so-called ABI),
alone or with “dry needling” (introduction of a fine needle),
usually to treat injured tendons; and
(b) other methods that involve centrifuging the blood,
which separates out a concentrated mix of plasma, etc., which
then is injected
into injured tissues in various conditions: Autologous
Conditioned Plasma (ACP) for tendons; Platelet Rich Plasma
(PRP) to treat “tennis elbow”; Blood-spinning, used by
professional athletes in a number of sports, i.e., tennis,
golf, football, soccer.
But to date there is no indication that any of these more complex methods is preferable to ABI. On the contrary, ABI seems to be better, or results are arguably mixed or inconclusive. And ABI is … autohemotherapy!
(3) Therapy with stem cells from
the blood rather than from bone marrow.
The field of stem cell therapy had
already become prominent as the cutting edge of medical science in
the early years of the new millennium (as seen in trends within
Medline & Google).
The past decade has seen further acceleration of the
replacement of bone-marrow transplantation
(BMT) with stem-cell transplantation (SCT).
The numbers of SCT articles listed in MEDLINE between
2006 and 2016 are nearly four times greater than the number of
BMT articles (60,360 versus 15,812). This is a dramatic
departure from historical trends prior to the past decade, when
articles on BMT out-numbered SCT articles two to one (63,632 to
32,158). As noted
in the case of non-Hodgkin’s
Lymphoma, “marrow collections have largely been abandoned in
favour of this safer and better procedure [i.e., “peripheral
blood stem cell harvest”] (www.nhlcyberfamily.org/treatments/collection.htm).
Thus stem cell therapy, which predominately uses stem
cells from blood, has for the most part become a form of
(concentrated) autohemotherapy.
(4)
the continuing association of autologous methods with cancer.
It
is striking that the vast majority of autologous immunization
methods in MEDLINE, both active and passive respectively, are
involved with cancer. This is of course a grand endorsement of
the use of autologous (or “personalized”) methods in the
treatment of cancer.
At the same time, the confusion over the meaning of
“active” versus “passive” Immunization continues, as discussed
in detail in Chapter 7, “Theoretical Considerations”. Sir Almroth Wright had
argued that “passive immunization” was actually “active
immunization”, as clearly evidenced by the observation that,
when effective, so-called "serum therapy" involved the application of
increasing doses in a similar fashion as with “vaccine-therapy”. To this we might well
add the success in general of autologous methods against cancer,
however they may be labeled.
If is autologous, by definition it comprises a
self-generated vaccine against one’s own cancer, providing
additional support for the Wright contention that so-called
“passive immunization” is indeed a form of “active
immunization”, as discussed in Chapters 1, 2 and 5.
--- Remembering "Autohemotherapist" Sam Tasker
(1907-1999) ---
When
I attempted to find a practitioner in Los Angeles in the early
1990's, I was able to make contact with a dermatologist, Sam
Tasker MD. Dr.
Tasker had been using autohemotherapy in his dermatology
practice for years, albeit on difficult cases. He clearly
characterized it as a “treatment of last resort” – if nothing
else worked, he would try autohemotherapy. Dr. Tasker used
a method he described as "the Russian method". This was
comprised of 3 cc of freshly drawn blood, with a small amount
residual air in the syringe, which was then briefly shaken to
more thoroughly mix the oxygen, and then nearly immediately
re-injected into the muscle in the upper-arm / shoulder.
He did not change the needle in the process, using the same size
needle, 25 x 5/8, for both withdrawing and re-injection. His
practice was to repeat the treatment as needed bi-weekly or
weekly.
Dr.
Tasker closed his practice in the 1990s and is longer with us.
Fortunately Dr. Tasker had consented to a lengthy interview
before his passing, available on YouTube, accessible through
instituteofscience.com or youtube.com (s h
shakman).
https://www.youtube.com/watch?v=K29GXlFiOCs&feature=related
https://www.youtube.com/watch?v=4cwjdL2-5ys
CASE STUDIES
Email: mail@instituteofscience.com
